LKLynn G. Kirby

Lynn G. Kirby

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lynn G. Kirby has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Chen Li

    Center for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, Philadelphia, USA

    5 shared publications
  • Emily Freeman-Daniels

    Department of Anatomy and Cell Biology, Temple University School of Medicine, Philadelphia, PA 19140, USA

    3 shared publications
  • Nicholas S. McCloskey

    Center for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, Philadelphia, USA

    3 shared publications
  • Sheryl G. Beck

    Department of Anesthesiology, University of Pennsylvania School of Medicine and Children’s Hospital of Philadelphia Research Institute, Philadelphia, USA

    3 shared publications
  • Adaure Akanwa

    Dept. of Anesthesiology, University of Pennsylvania School of Medicine and Children’s Hospital of Philadelphia, Philadelphia, PA 19104

    2 shared publications
  • Chen Li

    Center for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, Philadelphia, USA

    2 shared publications

Latest Publications

  • Open Access

    Behavioral impact of chemogenetic manipulations of 5-HT DRN neurons in transgenic Tph2-iCre rats

    by Nicholas S. McCloskey, Chen Li, Lynn G. Kirby

    Rationale: Our laboratory has demonstrated that stressors regulate the 5-HT system with consequences in behavioral models of psychiatric disorders including addiction. We have employed behavioral pharmacology methods to show that stressors engage corticotropin-releasing factor afferents to 5-HT dorsal raphe nucleus (DRN) neurons with effects on negative affective state and stress-induced opioid relapse models. Given the ongoing opioid crisis, there remains a need to elucidate the neural mechanisms underlying opioid use disorder with molecular, temporal and spatial precision using newer circuit manipulation strategies in animal models. Objectives: We sought to characterize the behavioral effects of chemogenetic manipulations of 5-HT DRN neurons in male and female Tph2-iCre rats. Methods: Subjects received intra-DRN viral infusions of Cre-dependent inhibitory or excitatory Designer Receptors Exclusively Activated by Designer Drugs (DREADDs). Three behavioral paradigms were used to examine the effect of clozapine-N-oxide activation or inhibition of 5-HT DRN neurons: elevated plus maze (EPM), forced swim test (FST), and stress-induced reinstatement of morphine conditioned place preference (CPP). Results: Chemogenetic activation of 5-HT DRN neurons induces anxiety-like behavior in the EPM in a transgenic rat model. Conclusions: This study confirms some of the findings of prior chemo- and optogenetic studies in mice showing a role of 5-HT DRN neurons in anxiety-like behaviors but did not support effects in the FST model or in reinstatement of morphine CPP. Given the growing availability of transgenic rat lines, future studies in transgenic rats are needed to help dissect a complex literature on the behavioral functions of the 5-HT system.


  • Open Access

    Exploring the effects of adolescent social isolation stress on the serotonin system and ethanol-motivated behaviors

    by Bryan D. McElroy, Chen Li, Nicholas S. McCloskey, Amber R. Alberici, Lynn G. Kirby

    Rationale: Alcohol is one of the most frequently used drugs of abuse and has a major impact on human health worldwide. People assigned female at birth and those with adverse childhood experiences are stress-vulnerable and more likely to report drinking as a means of “self-medication.” Prior studies in our laboratory showed that adolescent social isolation stress (SIS) increases vulnerability to ethanol (EtOH) intake and consumption despite negative consequences in female rats. Objectives: Here, we explored modulation of the dorsal raphe nucleus (DRN)-serotonin (5-HT) system, a sexually dimorphic neurotransmitter system involved in stress-reward interactions, to determine its contribution to EtOH-motivated behaviors in rats that have undergone SIS. Results: We employed electrophysiological and functional neuroanatomy strategies to show that both SIS and EtOH exposure induce persistent hypofunction of the DRN 5-HT system, particularly in females. Chemogenetic activation of DRN 5-HT neurons attenuated reward value for both EtOH and sucrose and elevated punished responding for EtOH in a stress-dependent manner. Conclusions: Our results highlight an inverse relationship between EtOH consumption and the 5-HT system, the sex- and stress-dependent nature of this relationship, and a connection between DRN 5-HT signaling and acute responding to rewards and punishment. These data support the DRN 5-HT system as a potential target to treat aberrant alcohol consumption and drinking despite negative consequences in stress-vulnerable populations.


  • Open Access

    Role of serotonin neurons in the dorsal raphe nucleus in heroin self-administration and punishment

    by Chen Li, Nicholas S. McCloskey, Saadet Inan, Lynn G. Kirby

    One hallmark of substance use disorder is continued drug use despite negative consequences. When drug-taking behavior is punished with aversive stimuli, i.e. footshock, rats can also be categorized into punishment-resistant or compulsive vs. punishment-sensitive or non-compulsive phenotypes. The serotonin (5-hydroxytryptamine, 5-HT) system modulates responses to both reward and punishment. The goal of the current study was to examine punishment phenotypes in heroin self-administration and to determine the role of dorsal raphe nucleus (DRN) 5-HT neurons in both basal and punished heroin self-administration. First, rats were exposed to punished heroin self-administration and neuronal excitability of DRN 5-HT neurons was compared between punishment-resistant and punishment-sensitive phenotypes using ex vivo electrophysiology. Second, DRN 5-HT neuronal activity was manipulated in vivo during basal and punished heroin self-administration using chemogenetic tools in a Tph2-iCre rat line. While rats separated into punishment-resistant and punishment-sensitive phenotypes for punished heroin self-administration, DRN 5-HT neuronal excitability did not differ between the phenotypes. While chemogenetic inhibition of DRN 5-HT neurons was without effect, chemogenetic activation of DRN 5-HT neurons increased both basal and punished heroin self-administration selectively in punishment-resistant animals. Additionally, the responsiveness to chemogenetic activation of DRN 5-HT neurons in basal self-administration and motivation for heroin in progressive ratio each predicted resistance to punishment. Therefore, our data support the role for the DRN 5-HT system in compulsive heroin self-administration.


  • Role of α1-GABAA receptors in the serotonergic dorsal raphe nucleus in models of opioid reward, anxiety, and depression

    by Chen Li, Bryan D McElroy, Jared Phillips, Nicholas S McCloskey, Xiangdang Shi, Ellen M Unterwald, Lynn G Kirby

    Background: The serotonin (5-hydroxytryptamine (5-HT))-mediated system plays an important role in stress-related psychiatric disorders and substance abuse. Our previous studies showed that stress and drug exposure can modulate the dorsal raphe nucleus (DRN)-5-HT system via γ-aminobutyric acid (GABA)A receptors. Moreover, GABAA receptor-mediated inhibition of serotonergic DRN neurons is required for stress-induced reinstatement of opioid seeking. Aim/methods: To further test the role of GABAA receptors in the 5-HT system in stress and opioid-sensitive behaviors, our current study generated mice with conditional genetic deletions of the GABAA α1 subunit to manipulate GABAA receptors in either the DRN or the entire population of 5-HT neurons. The GABAA α1 subunit is a constituent of the most abundant GABAA subtype in the brain and the most highly expressed subunit in 5-HT DRN neurons. Results: Our results showed that mice with DRN-specific knockout of α1-GABAA receptors exhibited a normal phenotype in tests of anxiety- and depression-like behaviors as well as swim stress-induced reinstatement of morphine-conditioned place preference. By contrast, mice with 5-HT neuron-specific knockout of α1-GABAA receptors exhibited an anxiolytic phenotype at baseline and increased sensitivity to post-morphine withdrawal-induced anxiety. Conclusions: Our data suggest that GABAA receptors on 5-HT neurons contribute to anxiety-like behaviors and sensitivity of those behaviors to opioid withdrawal.


  • CRF-5-HT interactions in the dorsal raphe nucleus and motivation for stress-induced opioid reinstatement

    by Chen Li, Nicholas McCloskey, Jared Phillips, Steven J. Simmons, Lynn G. Kirby

    Rationale The serotonin (5-hydroxytryptamine, 5-HT) system plays an important role in stress-related psychiatric disorders and substance abuse. Our previous data show that stressors can inhibit 5-HT neuronal activity and release by stimulating the release of the stress neurohormone corticotropin-releasing factor (CRF) within the serotonergic dorsal raphe nucleus (DRN). The inhibitory effects of CRF on 5-HT DRN neurons are indirect, mediated by CRF-R1 receptors located on GABAergic afferents. Objectives We tested the hypothesis that DRN CRF-R1 receptors contribute to stress-induced reinstatement of morphine-conditioned place preference (CPP). We also examined the role of this circuitry in stress-induced negative affective state with 22-kHz distress ultrasonic vocalizations (USVs), which are naturally emitted by rats in response to environmental challenges such as pain, stress, and drug withdrawal. Methods First, we tested if activation of CRF-R1 receptors in the DRN with the CRF-R1-preferring agonist ovine CRF (oCRF) would reinstate morphine CPP and then if blockade of CRF-R1 receptors in the DRN with the CRF-R1 antagonist NBI 35965 would attenuate swim stress–induced reinstatement of morphine CPP. Second, we tested if intra-DRN pretreatment with NBI 35965 would attenuate foot shock stress–induced 22-kHz USVs. Results Intra-DRN injection of oCRF reinstated morphine CPP, while intra-DRN injection of NBI 35965 attenuated swim stress–induced reinstatement. Moreover, intra-DRN pretreatment with NBI 35965 significantly reduced 22-kHz distress calls induced by foot shock. Conclusions These data provide evidence that stress-induced negative affective state is mediated by DRN CRF-R1 receptors and may contribute to reinstatement of morphine CPP.


  • Open Access

    Endocannabinoids, stress signaling, and the locus coeruleus-norepinephrine system

    by Ryan R. Wyrofsky, Beverly A.S. Reyes, Xiao-Yan Zhang, Seema Bhatnagar, Lynn G. Kirby, Elisabeth J. Van Bockstaele


  • Cannabinoid modulation of alpha2adrenergic receptor function in rodent medial prefrontal cortex

    by Alessandra M. Cathel, Beverly A. S. Reyes, Qin Wang, Jonathan Palma, Kenneth Mackie, Elisabeth J. Van Bockstaele, Lynn G. Kirby

    Endocannabinoids acting at the cannabinoid type 1 receptor (CB1R) are known to regulate attention, cognition and mood. Previous studies have shown that, in the rat medial prefrontal cortex (mPFC), CB1R agonists increase norepinephrine release, an effect that may be attributed, in part, to CB1Rs localised to noradrenergic axon terminals. The present study was aimed at further characterising functional interactions between CB1R and adrenergic receptor (AR) systems in themPFCusingin vitrointracellular electrophysiology and high‐resolution neuroanatomical techniques. Whole‐cell patch‐clamp recordings of layer V/VI cortical pyramidal neurons in rats revealed that both acute and chronic treatment with the synthetic CB1R agonist WIN 55,212‐2 blocked elevations in cortical pyramidal cell excitability and increases in input resistance evoked by the α2‐adrenergic receptor (α2‐AR) agonist clonidine, suggesting a desensitisation of α2‐ARs. These CB1R–α2‐AR interactions were further shown to be both action potential‐ and gamma‐aminobutyric acid‐independent. To better define sites of cannabinoid–AR interactions, we localised α2A‐adrenergic receptors (α2A‐ARs) in a genetically modified mouse that expressed a hemoagglutinin (HA) tag downstream of the α2A‐AR promoter. Light and electron microscopy indicated that HA‐α2A‐AR was distributed in axon terminals and somatodendritic processes especially in layer V of themPFC. Triple‐labeling immunocytochemistry revealed that α2A‐AR and CB1R were localised to processes that contained dopamine‐β‐hydroxylase, a marker of norepinephrine. Furthermore, HA‐α2A‐AR was localised to processes that were directly apposed to CB1R. These findings suggest multiple sites of interaction between cortical cannabinoid–adrenergic systems that may contribute to understanding the effect of cannabinoids on executive functions and mood.


  • Stress-dependent opioid and adrenergic modulation of newly retrieved fear memory

    by Allen M. Schneider, Peter E. Simson, Caitlin M. Daimon, Jakob Mrozewski, Nicholas M. Vogt, John Keefe, Lynn G. Kirby